Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,430.00
Bid: 1,429.00
Ask: 1,430.00
Change: 10.00 (0.70%)
Spread: 1.00 (0.07%)
Open: 1,429.50
High: 1,430.00
Low: 1,425.50
Prev. Close: 1,420.00
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

27 Oct 2008 07:00

RNS Number : 7023G
Persimmon PLC
27 October 2008
 



INTERIM MANAGEMENT STATEMENT

27 October 2008

Persimmon plc today releases its third quarter Interim Management Statement. This report has been brought forward from the previously announced date of 18 November 2008 in view of the impact that the recent significant events in financial markets have had on the UK housing market, in particular the further pressure being experienced on selling prices and, consequentially, residential land values.

We anticipate that our underlying trading results for the full year will be in line with expectations. We expect to legally complete c. 10,000 homes for the year ending 31 December 2008. Sales revenues for this year including legal completions to date are at c. £1.8 billion with a further c. £250 million of sales already taken for 2009.

Since we reported our Half Year results on 21 August 2008 we have encountered deteriorating trading conditions. The uncertainty created in the housing market by the increasingly turbulent and uncertain outlook in financial markets has had a negative impact on all our regions across the UK. The availability of mortgages has continued to be very restricted and cancellation rates have increased to c. 35% over recent weeks due to these market uncertainties. Sales conditions remain extremely competitive, while incentives and marketing costs are increasing leading to further margin pressures.

We continue to control all our costs tightly. As previously reported we are maintaining an extremely cautious approach to work in progress expenditure and continue with the planned reduction of our landbank in line with the scale of our business. We also remain focussed on increasing social housing sales volumes. This year we expect to increase these volumes by c. 25%.

When we announced our half year results in August we stated that we would continue to review the value of our land holdings in the light of market conditions.  During H1 2008 we experienced selling price weakness of c. 5%. At the half year stage we made a net realisable value provision against our land holdings of £40.0 million as a consequence of this price weakness together with the anticipation of a further c. 5% reduction in the second half of the year. As a result of the increased downward pressure on selling prices currently experienced, we now anticipate a c. 10% reduction for H2 2008 with this continuing trend of price falls.

From an accounting standpoint we have undertaken a thorough review of all our land based on prudent assumptions. This has resulted in a net realisable provision requirement of a further c. £600 million. The total provision represents c. 19% of stock value at June 2008 and would result in a pro forma net asset value at that date of c. 610 pence per share. The additional provision requirement will be accounted for in the second half and further details will be provided when we announce our Preliminary Results for the current year on 3 March 2009.

Despite the market deterioration, we expect our borrowings to have reduced during the second half, with our planned cash generation in line with previous guidance and that our debt will reduce further during 2009. The Group continues to comply with all its financing covenants.

We are fully supportive of the Government's initiatives to increase mortgage availability to 2007 levels. Until this begins to take effect we do not expect to see any improvement in trading conditions and we continue to carefully monitor all our activities. In the meantime our focus remains on generating cash and reducing overall working capital levels to maintain a strong balance sheet for the future.

Meeting details:

A meeting will be hosted by Mike Farley and Mike Killoran 

Time: 9am on 27 October 2008

Venue: Merrill Lynch, 2 King Edward StreetLondon EC1A 1HQ

To access the live conference call, please dial:

Tel: 0844 8000920 or 01296 311652

Passcode: 621 588

A replay facility will be available for 2 weeks:

Dial In: 0800 032 9687 or 0207 136 9233

Passcode: 22552440 

For further information, please contact:

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

On 27 October 2008: +44 (0) 20 7153 1533

After this date: Tel: +44 (0) 1904 642 199 

M: Communications

Edward Orlebar 

Tel: +44 (0) 207 153 1523 / +44 7738 724 630

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUNSARWORRUUA
Date   Source Headline
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.